Dr. Martin L.Pall

Las publicaciones científicas del Dr. Martin L.Pall desde el año 2001 son:

  1.  Pall, M. L.  2001. Cobalamin used in chronic fatigue syndrome therapy is a nitric oxide scavenger. Journal of Chronic Fatigue Syndr 8(2):39-44.
  2. Pall M. L, Satterlee J. D., 2001.   Elevated nitric oxide/peroxynitrite mechanism for the common etiology of multiple chemical sensitivity, chronic fatigue syndrome and posttraumatic stress disorder. Annals of the New York Academy of Sciences 933:323-329.
  3. Pall M. L.  2001.  Common etiology of posttraumatic stress disorder, fibromylagia, chronic fatigue syndrome and multiple chemical sensitivity via elevated nitric oxide/peroxynitrite.  Med Hypoth 57:139-145.
  4. Pall M. L. 2002.  The levels of nitric oxide synthase product, citrulline, are elevated in the sera of chronic fatigue syndrome patients.  J Chronic Fatigue Syndr 10(3/4):37-41.
  5. Pall M. L.  2002.  NMDA sensitization and stimulation by peroxynitrite, nitric oxide and organic solvents as the mechanism of chemical sensitivity in multiple chemical sensitivity.  FASEB J. 16:1407-1417.
  6. Pall, M. L.  2002  Chronic fatigue syndrome/myalgia encephalomyelitis.  Br J Gen Pract 52:762.
  7. Smirnova I.V., Pall M.L.  2003  Elevated levels of protein carbonyls in sera of chronic fatigue syndrome patients.  Mol Cell Biochem 248:93-95.
  8. Pall M. L. 2003.  Elevated nitric oxide/peroxynitrite theory of multiple chemical sensitivity:  Central role of N-methyl-D-aspartate receptors in the sensitivity mechanism.  Environ Health Perspect 111:1461-1464.
  9. Pall M. L.  2003 Long delayed sequelae of organophosphate exposure.  Arch Env Health 58:605.
  10. Pall M. L.  2004  The simple truth about multiple chemical sensitivity.  Environ Health Perspect 112:A266-A267.
  11. Pall M. L., Anderson J. H.  2004  The vanilloid receptor as a putative target of diverse chemicals in multiple chemical sensitivity.  Arch Environ Health 59:363-375.
  12. Pall M. L.  2005  Chronic fatigue syndrome and nitric oxide: giving credit where credit is due.  Med Hypoth 65:631-633.
  13. Pall M. L.  2005  Multiple chemical sensitivity: towards the end of controversy.  Townsend Let Doctors Patients Aug/Sept 2005:52-56.
  14. Pall M. L.  2006 The NO/ONOO- Cycle as the Cause of Fibromyalgia and Related Illnesses: Etiology, Explanation and Effective Therapy.  In, New Research in Fibromyalgia, Nova Science Publishers, Hauppauge, NY, pp 39-61.
  1. Pall M. L., Bedient S. A. 2007 The NO/ONOO Cycle as the Etiologic Mechanism of Tinnitus, Int Tinnitus J 13:99-104.
  2. Pall M. L. 2007  “Explaining ‘Unexplained Illness’: Disease Paradigm for Chronic Fatigue Syndrome, Multiple Chemical Sensitivity, Fibromyalgia, Post-Traumatic Stress Disorder, Gulf War Syndrome and Others”, 16 Chapter book, Harrington Park (Haworth) Press.
  3. Pall ML. 2007  Nitric oxide synthase partial uncoupling as a key switching mechanism for the NO/ONOO- cycle.  Med Hypotheses 69:821-825.
  4. Pall M. L. 2008  Post-radiation syndrome as a NO/ONOO- cycle, chronic fatigue syndrome-like disease.  Med Hypoth 78:537-541.
  5. Pall M. L. 2008  Does sauna therapy used to treat multiple chemical sensitivity and other diseases act by increasing availability of tetrahydrobiopterin?  Med Hypoth 73:610-613.
  6. Pall M. L. 2009  Multiple chemical sensitivity:  Toxicological questions and mechanisms.  In General and Applied Toxicology, 3rd Edition, John Wiley & Sons, pp. 2303-2352.
  7. Pall M. L. 2010 The NO/ONOO-  Vicious Cycle Mechanism as the Cause of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis,  In Chronic Fatigue Syndrome: Symptoms, Causes and Prevention, Edita Svoboda and Kristof Zelenjcik, eds., Nova Publishers, pp 27-56.
  8. Pall M. L. 2010  How Can We Cure NO/ONOO- Cycle Diseases?  Approaches to curing chronic fatigue syndrome/myalgic encephalomyelitis, fibromyalgia, multiple chemical sensitivity, Gulf War syndrome and possibly many others, Townsend Letter for Doctors and Patients, Feb/Mar 2010:75-84.
  9. Pall M.L. 2010  High-dose therapy for ascorbate, niacin, folate and B-12:  Pauling was right but for the wrong reason.  J Orthomolecular Med 25(3):148-156.
  10. Pall M. L. 2010  Multiple chemical sensitivity is a response to chemicals acting as toxicants via excessive NMDA activity.  J Psychosomatic Res 69: 327-328.
  11. Pall, M.L. Teufelskreis NO/ONOO–Zyklus, oxidaver Stress, mitochondriale, inflammatorische und neurologische Dysfunktion.  Umwelt Medizin Gesellshaft 2010, 23, 281-293.
  12. Hoeck A. D., Pall M. L. 2011 Will vitamin D supplementation ameliorate diseases characterized by chronic inflammation and fatigue?  Med Hypotheses 76: 208-213.
  13. Carruthers B. M. et al (including Pall M. L.) 2011  Myalgic enchephalomyelitis:  International consensus criteria.  J Intern Med 270: 327-338.
  14. Pall ML 2012  Chronic fatigue syndrome and fibromyalgia are NO/ONOO- cycle diseases, not glutathione depletion/methylation cycle block diseases: an analysis of the Nathan/Van Konyneburg data.  Towsend Lett April 2012:75-79.
  15. Pall ML. 2013 Pulmonary hypertension is a probable NO/ONOO- cycle disease: A review.  ISRN Hypertension 2013: Article ID 742418, 27 pages.
  16. Pall ML. 2012 Two fragrance chemicals may act as toxicants via TRPA1 stimulation rather than via direct mitochondrial action. Toxicol In Vitro. 2012 Sep 25. pii: S0887-2333(12)00265-2. doi: 10.1016/j.tiv.2012.09.011. [Epub ahead of print]
  17. Pall ML. 2013  Electromagnetic fields act via activation of voltage-gated calcium channels to produce beneficial or adverse effects. J Cell Mol Med 17:958-965.
  18. Auhdya T., Pall M.L., Green J. 2013 A Study of Sauna Therapy in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients Shows Sauna Action via Raised Tetrahydrobiopterin and Three Predictions of the NO/ONOO- Cycle.  Townsend Lett 364:60-64.
  19. Pall ML. The NO/ONOO- Cycle as the Central Cause of Heart Failure.  Int J Mol Sci Nov 13;14(11):22274-330. doi: 10.3390/ijms141122274.
  20. Pall ML. 2014 Electromagnetic field activation of voltage-gated calcium channels: role in therapeutic effects.  Electromagn Biol Med. 2014 Apr 8.
  21. Pall ML. 2014   Is Open-angle Glaucoma Caused by the NO/ONOO(-) Cycle Acting at Two Locations in the Eye?  Med Hypothesis Discov Innov Ophthalmol 4:1-2.
  22. Pall ML, Levine S. 2015 Nrf2, a master regulator of detoxification and also antioxidant, anti- inflammatory and other cytoprotective mechanisms, is raised by health promoting factors. Acta Physiologica Sinica, February 25, 2015, 67(1): 1–18.
  23. Pall ML. 2015  Scientific evidence contradicts findings and assumptions of Canadian Safety Panel 6: microwaves act through voltage-gated calcium channel activation to induce biological impacts at non-thermal levels, supporting a paradigm shift for microwave/lower frequency electromagnetic field action.  Rev Environ Health 30:99-116.
  24. Pall ML, Levine S. 2015 Nrf2 is a master regulator of cytoprotective responses including antioxidant, anti-inflammatory, detoxification, improved mitochondrial function and autophagy: Nrf2 activity is raised by many health-promoting factors.  Townsend Lett,  October 2015 : 51-54.
  25. Pall ML. 2015 Microwave frequency electromagnetic fields (EMFs) produce widespread neuropsychiatric effects including depression. J Chem Neuroanatomy, 2015 Aug 21. pii: S0891-0618(15)00059-9. doi: 10.1016/j.jchemneu.2015.08.001. [Epub ahead of print]
  26. Pall ML. 2015 How to approach the challenge of minimizing non-thermal health effects of microwave radiation from electrical devices. International Journal of Innovative Research in Engineering & Management (IJIREM) ISSN: 2350-0557, Volume-2, Issue -5, September 2015; 71-76.
  27. Pall ML. 2015 Elektromagnetische Felder wirken über die Aktivierung spannungsabhängiger Calciumkanäle, um günstige oder ungünstige Wirkungen zu erzeugen.  Umwelt-Medizin-Gesellshaft 28(1): 22-31.
  28. Pall ML. 2016  Electromagnetic fields act similarly in plants as in animals: Probable activation of calcium channels via their voltage sensor.  Curr Chem Biol 10: 74-82.